Micronized flavonoid therapy in internal hemorrhoids of pregnancy.
OBJECTIVE
To assess the safety, efficacy and acceptability of a micronized flavonoid formulation in the treatment of internal hemorrhoids of pregnancy.


METHODS
In an open study on hospital outpatients, we studied therapy with micronized diosmin 90% and hesperidin 10% for a median of 8 weeks before delivery and 4 weeks after delivery, in 50 women with acute hemorrhoids. The outcome measures were symptoms and signs of hemorrhoids; adverse effects; and acceptability of treatment.


RESULTS
On intention to treat analysis, 66% (95% confidence interval, range 79.1-52.9) had relief from acute symptoms by the 4th day; 53.6% (95% confidence interval, range 70-37.1, P < 0.001) fewer patients had relapse in the antenatal period. Treatment was well accepted, and did not affect pregnancy, fetal development, birth weight, infant growth and feeding.


CONCLUSIONS
In the short term, micronized diosmin 90% and hesperidin 10% is safe, acceptable, and effective in the treatment of hemorrhoids of pregnancy.
Buckshee
K
K
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
Takkar
D
D
Aggarwal
N
N
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D016009:Chi-Square Distribution; D016001:Confidence Intervals; D004145:Diosmin / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004339:Drug Compounding; D005260:Female; D006484:Hemorrhoids / Q000188:drug therapy* / Q000209:etiology; D006569:Hesperidin / Q000008:administration & dosage*; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011446:Prospective Studies; D016896:Treatment Outcome
D004145:Diosmin; D006569:Hesperidin